Atria Investments LLC Ascendis Pharma A/S Transaction History

Atria Investments LLC

$8.14 Billion
Q3 2025

A detailed history of Atria Investments LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Atria Investments LLC holds 4,263 shares of ASND stock, worth $871,357. This represents 0.01% of its overall portfolio holdings.

Number of Shares

4,263

Previous 4,416 3.46%

Holding current value

$871,357

Previous $762,000 11.15%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 06, 2025	SELL	$163.32 - $205.91 $24,987 - $31,504	-153 Reduced 3.46%	4,263 $847,000
Q2 2025 Aug 04, 2025	BUY	$137.41 - $179.1 $270,835 - $353,006	1,971 Added 80.61%	4,416 $762,000
Q1 2025 May 06, 2025	BUY	$119.49 - $168.84 $1,075 - $1,519	9 Added 0.37%	2,445 $381,000
Q4 2024 Feb 06, 2025	BUY	$122.0 - $146.6 $47,946 - $57,613	393 Added 19.24%	2,436 $335,000
Q3 2024 Nov 01, 2024	BUY	$113.0 - $153.43 $678 - $920	6 Added 0.29%	2,043 $305,000

Q2 2024 Aug 13, 2024	BUY	$121.07 - $153.67 $246,619 - $313,025	2,037 New	2,037 $277,000
Q2 2022 Aug 11, 2022	SELL	$78.08 - $117.61 $833,425 - $1.26 Million	-10,674 Closed	0 $0
Q1 2022 May 02, 2022	BUY	$102.18 - $135.75 $112,193 - $149,053	1,098 Added 11.47%	10,674 $1.25 Million
Q4 2021 Feb 04, 2022	BUY	$127.1 - $169.66 $11,184 - $14,930	88 Added 0.93%	9,576 $1.29 Million
Q3 2021 Nov 16, 2021	SELL	$112.67 - $176.92 $75,601 - $118,713	-671 Reduced 6.6%	9,488 $1.51 Million
Q2 2021 Aug 10, 2021	BUY	$121.62 - $145.29 $115,174 - $137,589	947 Added 10.28%	10,159 $1.34 Million
Q1 2021 May 11, 2021	BUY	$124.92 - $173.33 $296,185 - $410,965	2,371 Added 34.66%	9,212 $1.19 Million
Q4 2020 Feb 12, 2021	BUY	$151.2 - $182.76 $505,612 - $611,149	3,344 Added 95.62%	6,841 $1.14 Million
Q1 2020 May 15, 2020	SELL	$97.01 - $145.11 $175,782 - $262,939	-1,812 Reduced 34.13%	3,497 $394,000
Q4 2019 Feb 11, 2020	BUY	$91.45 - $139.12 $485,508 - $738,588	5,309 New	5,309 $739,000
Q3 2019 Nov 14, 2019	SELL	$95.8 - $118.9 $427,842 - $531,007	-4,466 Closed	0 $0
Q2 2019 Aug 26, 2019	BUY	$107.11 - $132.09 $478,353 - $589,913	4,466 New	4,466 $509,000
Q2 2019 Aug 09, 2019	SELL	$107.11 - $132.09 $433,688 - $534,832	-4,049 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$62.15 - $129.99 $41,826 - $87,483	-673 Reduced 14.25%	4,049 $477,000
Q4 2018 Feb 12, 2019	SELL	$55.16 - $69.67 $6,453 - $8,151	-117 Reduced 2.42%	4,722 $296,000
Q3 2018 Oct 09, 2018	SELL	$63.77 - $76.28 $8,162 - $9,763	-128 Reduced 2.58%	4,839 $343,000
Q2 2018 Jul 13, 2018	BUY	$58.55 - $73.92 $101,350 - $127,955	1,731 Added 53.49%	4,967 $330,000
Q1 2018 Apr 30, 2018	BUY	$38.98 - $68.04 $126,139 - $220,177	3,236 New	3,236 $212,000

Others Institutions Holding ASND

# of Institutions

315

Shares Held

65.2M

Call Options Held

476K

Put Options Held

142K

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $11.4B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atria Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atria Investments LLC with notifications on news.

Account

Atria Investments LLC Ascendis Pharma A/S Transaction History